Skip to content

Precision TMS Intervention Research in Patients with Autism Spectrum Disorder Based on Individualized Multimodal Brain Atlases

Precision TMS Intervention Research in Patients with Autism Spectrum Disorder Based on Individualized Multimodal Brain Atlases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600119566
Enrollment
Unknown
Registered
2026-02-28
Start date
2026-03-30
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Experimental group:Receive precision rTMS intervention based on individualized multimodal brain atlases

Sponsors

Shandong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1.Outpatients or inpatients aged 3 to 17 years (inclusive), of any gender, right-handed; 2.Meeting the DSM-5 diagnostic criteria for ASD, confirmed by ADI-R and ADOS-2 assessments; 3.articipants agreeing to undergo scale evaluations, MRI scans, TMS therapy, and full cooperation throughout the study; guardians of participants signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Severe or unstable medical conditions, including neurological, endocrine, and rheumatic diseases, brain disorders, traumatic brain injury or surgery, and infectious diseases; 2.History of rTMS or electroconvulsive therapy within the past 3 months; 3.Contraindications to MRI scans and TMS therapy, including cardiac pacemakers, neurostimulators, artificial metal heart valves, intracranial aneurysm clips, cochlear implants, and other types of metallic implants (excluding dental braces); 4.Current severe and unstable psychiatric comorbidities (e.g., major depressive episode, acute schizophrenia, etc.), which the investigator judges may interfere with study assessments or increase participant risks; participants with stable mild comorbidities such as anxiety or attention deficit hyperactivity disorder are allowed to enroll, but their diagnosis and medication status must be documented in detail; personal or family history of epilepsy; 5.Pregnancy.

Design outcomes

Primary

MeasureTime frame
Rush Behavior Rating Scale - Revised score;Wechsler Intelligence Scale for Children - Fifth Edition score;Aberrant Behavior Checklist score;Social Responsiveness Scale score;

Secondary

MeasureTime frame
Changes in the FA value of white matter fibers;

Countries

China

Contacts

Public ContactDuanwei Wang

Shandong Mental Health Center

wren925@163.com+86 531 8633 6713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026